Varaico: Literature-Extracted Genetic Variants

Gene:BRAF
Variant:p.N20S
Back to variants list

BRAF

NM_004333.6:p.N20S

Associated Papers

Loss of Heterozygosity and Mutations in the RAS-ERK Pathway Genes in Tumor Cells of Various Loci in Multiple Myeloma.

Soloveva M et al.

International Journal of Molecular Sciences, 2024

39273371 (PubMed )
Supplement: ijms-25-09426-s001.zip › Supp_Initial_Data.xls › parametrs

Dynamics of RAS Mutations in Liquid Biopsies in Metastatic Colorectal Cancer Patients-Case Series and Literature Review.

Popescu I et al.

Journal of Personalized Medicine, 2024

39064004 (PubMed )
Supplement: jpm-14-00750-s001.zip › jpm-3006960-supplementary.pdf

Japanese Society of Medical Oncology clinical guidelines: Molecular testing for colorectal cancer treatment, 5th edition.

Bando H et al.

Cancer Science, 2024

38263580 (PubMed )
Supplement: CAS-115-1014-s001.docx

Clinical Validation of Plasma-Based Genotyping for RAS and BRAF V600E Mutation in Metastatic Colorectal Cancer: SCRUM-Japan GOZILA Substudy.

Aoki Y et al.

Jco Precision Oncology, 2023

KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas.

Martianov AS et al.

International Journal of Molecular Sciences, 2023

Utility of ctDNA Liquid Biopsies from Cancer Patients: An Institutional Study of 285 ctDNA Samples.

Gumà J et al.

Cancers, 2022

36497340 (PubMed )
Supplement: cancers-14-05859-s001.zip › cancers-2069645-supplementary.pdf

Custom multi‑tumor next‑generation sequencing panel for routine molecular diagnosis of solid tumors: Validation and results from three‑year clinical use.

Chevrier S et al.

International Journal of Molecular Medicine, 2022

35244186 (PubMed )
Supplement: Supplementary_Data2.xlsx › Feuil1

Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer.

Taniguchi F et al.

Future Science Oa, 2021

34840814 (PubMed )
Supplement: fsoa-07-757-s2.xlsx › Sheet1

RAS-targeted therapies: is the undruggable drugged?

Moore AR et al.

Nature Reviews. Drug Discovery, 2020

Comprehensive genomic profiling of high-grade serous ovarian carcinoma from Chinese patients identifies co-occurring mutations in the Ras/Raf pathway with TP53.

Zhong F et al.

Cancer Medicine, 2019

31124283 (PubMed )
Supplement: CAM4-8-3928-s005.pdf

Clinical Validation of Newly Developed Multiplex Kit Using Luminex xMAP Technology for Detecting Simultaneous RAS and BRAF Mutations in Colorectal Cancer: Results of the RASKET-B Study.

Taniguchi H et al.

Neoplasia (new York, N.y.), 2018

30412858 (PubMed )
Supplement: mmc1.docx

Rapid Somatic Mutation Testing in Colorectal Cancer by Use of a Fully Automated System and Single-Use Cartridge: A Comparison with Next-Generation Sequencing.

Al-Turkmani MR et al.

The Journal of Applied Laboratory Medicine, 2018

Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, Third Edition.

Yamazaki K et al.

Cancer Science, 2018

29873882 (PubMed )
Supplement: CAS-109-2074-s001.pdf

Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma.

Liang WS et al.

Genome Research, 2017

Fully automated PCR detection of KRAS mutations on pancreatic endoscopic ultrasound fine-needle aspirates.

de Biase D et al.

Journal of Clinical Pathology, 2016

Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers.

Haley L et al.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2015

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."